help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, S.
Right arrow Articles by Bahn, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, S.
Right arrow Articles by Bahn, R. S.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 930-935
Copyright © 2004 by The Endocrine Society

Evidence for Enhanced Adipogenesis in the Orbits of Patients with Graves’ Ophthalmopathy

Seema Kumar, Michael J. Coenen, Philipp E. Scherer and Rebecca S. Bahn

Divisions of Pediatric Endocrinology (S.K.) and Endocrinology, Metabolism, and Nutrition (M.J.C., R.S.B.), Mayo Clinic, Rochester, Minnesota 55905; and Department of Cell Biology and Diabetes Research and Training Center, Albert Einstein College of Medicine (P.E.S.), Bronx, New York 10461

Address all correspondence and requests for reprints to: Rebecca S. Bahn, M.D., Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. E-mail: bahn.rebecca{at}mayo.edu.

The signs and symptoms of Graves’ ophthalmopathy (GO) result from increased volume of the orbital contents, including adipose, connective, and extraocular muscle tissues. We wanted to determine whether the expanded adipose tissue volume might be in part attributable to de novo adipogenesis. We measured levels of mRNA encoding leptin, adiponectin, peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}), preadipocyte factor-1, and TSH receptor (TSHr) genes in orbital adipose tissues from GO patients (n = 22) and normal individuals (n = 18) and in orbital preadipocyte cultures derived from GO patients (n = 6) and normal subjects (n = 3) using quantitative real-time RT PCR. We found increased leptin, adiponectin, PPAR{gamma}, and TSHr expression in GO compared with normal orbital tissue samples, with positive correlations in the GO tissues between TSHr and leptin, adiponectin and PPAR{gamma}. In vitro differentiation of GO and normal preadipocytes resulted in enhanced adiponectin, leptin, and TSHr expression, with greater expression of the latter two genes in the GO cultures. These results suggest that de novo adipogenesis within orbital tissues with parallel enhanced expression of TSHr may be important in the pathogenesis of GO, and that potential therapies for GO might include inhibition of the adipogenic pathway.

This work was supported in part by NIH Grant EYO8819 (to R.S.B.) from the National Eye Institute.

Abbreviations: FBS, Fetal bovine serum; GO, Graves’ ophthalmopathy; PPAR{gamma}, peroxisome proliferator-activated receptor {gamma}; pref-1, preadipocyte factor-1; rRNA, ribosomal RNA; TSHr, TSH receptor.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
A. Antonelli, S. M. Ferrari, P. Fallahi, S. Frascerra, E. Santini, S. S. Franceschini, and E. Ferrannini
Monokine Induced by Interferon {gamma} (IFN{gamma}) (CXCL9) and IFN{gamma} Inducible T-Cell {alpha}-Chemoattractant (CXCL11) Involvement in Graves' Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-{gamma} Agonists
J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1803 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M.-H. Chen, S.-L. Liao, M.-H. Chen, P.-L. Tsou, M.-J. Shih, T.-C. Chang, and L.-M. Chuang
Lysosome-Related Genes Are Regulated in the Orbital Fat of Patients with Graves' Ophthalmopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4760 - 4764.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
L Liu, P Yang, H He, X Lin, L Jiang, W Chi, C Zhao, and H Zhou
Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion
Br. J. Ophthalmol., April 1, 2008; 92(4): 557 - 561.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Lu and R.-Y. Lin
TSH stimulates adipogenesis in mouse embryonic stem cells
J. Endocrinol., January 1, 2008; 196(1): 159 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
I. Cozma, L. Zhang, J. Uddin, C. Lane, A. Rees, and M. Ludgate
Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1630 - E1635.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
T J Cawood, P Moriarty, C O'Farrelly, and D O'Shea
The effects of tumour necrosis factor-{alpha} and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis
Eur. J. Endocrinol., September 1, 2006; 155(3): 395 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
O. F. Lai, N. Zaiden, S. S. Goh, N.-E. Mohamed, L. L. Seah, K. S. Fong, V. Estienne, P. Carayon, S. C. Ho, and D. H C Khoo
Detection of thyroid peroxidase mRNA and protein in orbital tissue.
Eur. J. Endocrinol., August 1, 2006; 155(2): 213 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases
Endocr. Rev., August 1, 2006; 27(5): 449 - 467.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M.-J. Shih, S.-L. Liao, K.-T. Kuo, T. J. Smith, and L.-M. Chuang
Molecular Pathology of Muller's Muscle in Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1159 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Antonelli, M. Rotondi, S. M. Ferrari, P. Fallahi, P. Romagnani, S. S. Franceschini, M. Serio, and E. Ferrannini
Interferon-{gamma}-Inducible {alpha}-Chemokine CXCL10 Involvement in Graves' Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-{gamma} Agonists
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 614 - 620.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kumar, A. Leontovich, M. J. Coenen, and R. S. Bahn
Gene Expression Profiling of Orbital Adipose Tissue from Patients with Graves' Ophthalmopathy: A Potential Role for Secreted Frizzled-Related Protein-1 in Orbital Adipogenesis
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4730 - 4735.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Lantz, T. Vondrichova, H. Parikh, C. Frenander, M. Ridderstrale, P. Asman, M. Aberg, L. Groop, and B. Hallengren
Overexpression of Immediate Early Genes in Active Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4784 - 4791.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
P. Agretti, G. De Marco, M. De Servi, C. Marcocci, P. Vitti, A. Pinchera, and M. Tonacchera
Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation
Eur. J. Endocrinol., May 1, 2005; 152(5): 777 - 784.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society